Haemophilus influenzae
"Economisation of Vaccination Against Haemophilus influenzae Type b: A Randomised Trial of Immunoaffinity of Fractional-Dose and Two-Dose Regimens."
Published in Vaccine Weekly, July 13th, 1998
According to the authors' abstract of an article published in Lancet, "Background: The cost of Haemophilus influenzae type b (Hib) conjugate vaccines has limited their use in non-industrialised countries. To identify more economical vaccination schedules, we carried out a randomised trial of the immunogenicity of alternative regimens to the standard three-dose series. Methods: 627 Chilean infants were randomly allocated to one of four regimens with either Hib polysaccharide-tetanus toxoid conjugate vaccine (PRP-T) or Hib oligosaccharide-diphtheria mutant toxoid conjugate vaccine (PRP-CRM197), for a total of eight groups. All infants receive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1998-07-13)
More Articles from Vaccine Weekly
- Conference Coverage (1st Annual Vaccine Research)
NIH Advised To Hand Over AIDS Vaccine Leadership - Conference Coverage
CDC Shows Allergic Reactions Linked to Vaccine Gelatin - Conference Coverage (12th World AIDS)
Thymus Transplants May Aid AIDS Kids - Conference Coverage (12th World AIDS)
Unsafe Sex Common In Republic of Georgia Teens - HSV-2
Vaginal Immunization Protects against High-Dose Wild-Type Virus Challenge - Industry News (RSV)
Therapeutic Monoclonal Antibody Approved for Respiratory Syncytial Virus Disease - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
